
Rohto Pharmaceutical Investor Relations Material
Latest events

Q1 2026
6 Aug, 2025

Q4 2025
13 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Rohto Pharmaceutical Co. Ltd
Access all reports
Rohto Pharmaceutical Co., Ltd. is a Japanese multinational corporation specializing in health and beauty care products. The company's main business activities include the manufacture and sale of pharmaceutical products, cosmetics, and functional foods. Rohto Pharmaceutical's product range spans eye care, including eye drops and lotions; skincare, featuring dermatological preparations, lip balms, and sunscreens; and oral medications, which include digestive medicines and Chinese herbal supplements. Additionally, the company offers extracorporeal test drugs and various other health-related products. The company is headquartered in Osaka, Japan, and its shares are listed on the Tokyo Stock Exchange.
Key slides for Rohto Pharmaceutical Co. Ltd


Q3 2025
Rohto Pharmaceutical Co. Ltd


Q1 2026
Rohto Pharmaceutical Co. Ltd
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
4527
Country
🇯🇵 Japan